The Hippo signaling network and its biological functions
Hippo signaling is an evolutionarily conserved network that has a central role in regulating
cell proliferation and cell fate to control organ growth and regeneration. It promotes …
cell proliferation and cell fate to control organ growth and regeneration. It promotes …
Recent therapeutic approaches to modulate the Hippo pathway in oncology and regenerative medicine
ER Barry, V Simov, I Valtingojer, O Venier - Cells, 2021 - mdpi.com
The Hippo pathway is an evolutionary conserved signaling network that regulates essential
processes such as organ size, cell proliferation, migration, stemness and apoptosis …
processes such as organ size, cell proliferation, migration, stemness and apoptosis …
[HTML][HTML] Glycogen accumulation and phase separation drives liver tumor initiation
Q Liu, J Li, W Zhang, C **ao, S Zhang, C Nian, J Li… - Cell, 2021 - cell.com
Glucose consumption is generally increased in tumor cells to support tumor growth.
Interestingly, we report that glycogen accumulation is a key initiating oncogenic event during …
Interestingly, we report that glycogen accumulation is a key initiating oncogenic event during …
The Hippo/YAP pathway interacts with EGFR signaling and HPV oncoproteins to regulate cervical cancer progression
The Hippo signaling pathway controls organ size and tumorigenesis through a kinase
cascade that inactivates Yes‐associated protein (YAP). Here, we show that YAP plays a …
cascade that inactivates Yes‐associated protein (YAP). Here, we show that YAP plays a …
YAP-induced PD-L1 expression drives immune evasion in BRAFi-resistant melanoma
MH Kim, CG Kim, SK Kim, SJ Shin, EA Choe… - Cancer immunology …, 2018 - AACR
Activation of YAP, a Hippo pathway effector, is an important resistance mechanism to BRAF
inhibitor (BRAFi) in melanoma. Emerging evidence also suggests that YAP is involved in …
inhibitor (BRAFi) in melanoma. Emerging evidence also suggests that YAP is involved in …
The Hippo coactivator YAP1 mediates EGFR overexpression and confers chemoresistance in esophageal cancer
S Song, S Honjo, J **, SS Chang, AW Scott… - Clinical Cancer …, 2015 - AACR
Purpose: Esophageal cancer is an aggressive malignancy and often resistant to therapy.
Overexpression of EGFR has been associated with poor prognosis of patients with …
Overexpression of EGFR has been associated with poor prognosis of patients with …
[HTML][HTML] YAP1 and TAZ control pancreatic cancer initiation in mice by direct up-regulation of JAK–STAT3 signaling
R Gruber, R Panayiotou, E Nye, B Spencer-Dene… - Gastroenterology, 2016 - Elsevier
Background & Aims Pancreatitis is the most important risk factor for pancreatic ductal
adenocarcinoma (PDAC). Pancreatitis predisposes to PDAC because it induces a process …
adenocarcinoma (PDAC). Pancreatitis predisposes to PDAC because it induces a process …
Yes-associated protein (YAP) in pancreatic cancer: at the epicenter of a targetable signaling network associated with patient survival
Pancreatic ductal adenocarcinoma (PDAC) is generally a fatal disease with no efficacious
treatment modalities. Elucidation of signaling mechanisms that will lead to the identification …
treatment modalities. Elucidation of signaling mechanisms that will lead to the identification …
Differential growth triggers mechanical feedback that elevates Hippo signaling
Mechanical stress can influence cell proliferation in vitro, but whether it makes a significant
contribution to growth control in vivo, and how it is modulated and experienced by cells …
contribution to growth control in vivo, and how it is modulated and experienced by cells …
Targeting the Hippo pathway for breast cancer therapy
L Wu, X Yang - Cancers, 2018 - mdpi.com
Breast cancer (BC) is one of the most prominent diseases in the world, and the treatments
for BC have many limitations, such as resistance and a lack of reliable biomarkers. Currently …
for BC have many limitations, such as resistance and a lack of reliable biomarkers. Currently …